Key points are not available for this paper at this time.
Whilst MEP implementation reduces acyclovir usage in patients evaluated for ME, the benefits in terms of antibiotic use, and length of stay are variable and likely depend on the study population, implementation strategy and standard of care testing available in each institution.
Rafiei et al. (Sat,) studied this question.